Mohr Davidow Ventures

company

About

Mohr Davidow invested in early-stage technology-based startups to create large new markets.

  • 1 - 10

Details

Industries
Banking,Finance,Venture Capital
Founded date
Jan 1, 1983
Number Of Employee
1 - 10
Operating Status
Active
Investor Type
Venture Capital

For 30 years the _Mohr Davidow Ventures team has invested in early stage technology-based startups that redefine or create large new markets. They believe that emerging information technology innovations are enabling a decade-long opportunity to invest in the “Era of Digital Engagement,” one in which personal, commercial, and public sector interactions of all kinds will be profoundly reengineered to leverage the power of mobile devices, cloud computing, and data analytics. The Firm seeks to identify and partner with exceptional entrepreneurs who leverage these technologies to build companies where seamless, deep engagement with customers will create billion dollar markets in a number of different verticals. These verticals include: Digital Marketing, Advertising, & Media, Collaborative Enterprise Applications, The Digitization of Education and Health, Digital Financial Services, E‐commerce & Digital Retail Innovation, Mobile/Web‐Powered “LifeTech.” The Firm also has previous investments in the innovative life sciences & genomics space.

Leading companies funded by Mohr Davidow Ventures includes: Agile (Acquired by NYSE: ORCL); Aryaka Networks; Brocade; Coupa; Genomatica; HealthTap; Infusionsoft; Kabbage; nLight; ONI Systems (Acquired by NASDAQ: CIEN); Proofpoint (NASDAQ: PFPT); Rally Software (NYSE: RALY); Rocket Fuel (NASDAQ: FUEL); Rambus; Shutterfly (NASDAQ: SFLY); Ticketfly; Verinata Health (Acquired by NASDAQ: ILMN); and Visible Measures. The Firm has $1.85 billion under management.

Investments

Number of Investments
Number of Lead Investments
13
2
Mohr Davidow Ventures has made 13 investments. Their most recent investment was on Apr 8, 2019, when Kabbage raised $700M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 8, 2019 Kabbage
Debt Financing $700M Consumer Lending
Jan 13, 2015 Personalis
Series C $33M Biotechnology
May 5, 2014 Kabbage
Series D $50M Consumer Lending
Oct 7, 2013 Personalis
Series B $22M Biotechnology
Sep 17, 2012 Kabbage
Series C $30M Consumer Lending